Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Molecular and Cellular Biology
|
November 26, 2002
The EBF/Olf/Collier family of transcription factors: regulators of differentiation in cells originating from all three embryonal germ layers
David Liberg, Mikael Sigvardsson, Peter Akerblad
Endocrine, Metabolic & Immune Disorders Drug Targets
|
March 17, 2015
S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer
Tomas Leanderson, David Liberg, Fredrik Ivars
Trends in Immunology
|
November 5, 2003
Upstream of Ikaros
David Liberg, Stephen T Smale, Matthias Merkenschlager
European Journal of Immunology
|
July 29, 2006
CArG box-binding factor-A interacts with multiple motifs in immunoglobulin promoters and has a regulated subcellular distribution
Alaitz Aranburu, David Liberg, Bent Honoré, et al.
Biochemical and Biophysical Research Communications
|
May 2, 2006
SPI-C and STAT6 can cooperate to stimulate IgE germline transcription
Robert Carlsson, Kaisa Thorell, David Liberg, et al.
BMC Immunology
|
December 14, 2012
CD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden
Eva Källberg, Martin Stenström, David Liberg, et al.
Molecular and Cellular Biology
|
October 23, 2002
Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation
Peter Akerblad, Ulrika Lind, David Liberg, et al.
Gene
|
December 3, 2002
Genomic structure of mouse SPI-C and genomic structure and expression pattern of human SPI-C
Robert Carlsson, Anna Hjalmarsson, David Liberg, et al.
Journal of Leukocyte Biology
|
July 2, 2003
RNA analysis of B cell lines arrested at defined stages of differentiation allows for an approximation of gene expression patterns during B cell development
Panagiotis Tsapogas, Thomas Breslin, Sven Bilke, et al.
Cancer Immunology, Immunotherapy : CII
|
August 29, 2022
Blockade of IL-1α and IL-1β signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy
Camilla Rydberg Millrud, Adnan Deronic, Caitríona Grönberg, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Molecular and Cellular Biology
|
November 26, 2002
The EBF/Olf/Collier family of transcription factors: regulators of differentiation in cells originating from all three embryonal germ layers
David Liberg, Mikael Sigvardsson, Peter Akerblad
Endocrine, Metabolic & Immune Disorders Drug Targets
|
March 17, 2015
S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer
Tomas Leanderson, David Liberg, Fredrik Ivars
Trends in Immunology
|
November 5, 2003
Upstream of Ikaros
David Liberg, Stephen T Smale, Matthias Merkenschlager
European Journal of Immunology
|
July 29, 2006
CArG box-binding factor-A interacts with multiple motifs in immunoglobulin promoters and has a regulated subcellular distribution
Alaitz Aranburu, David Liberg, Bent Honoré, et al.
Biochemical and Biophysical Research Communications
|
May 2, 2006
SPI-C and STAT6 can cooperate to stimulate IgE germline transcription
Robert Carlsson, Kaisa Thorell, David Liberg, et al.
BMC Immunology
|
December 14, 2012
CD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden
Eva Källberg, Martin Stenström, David Liberg, et al.
Molecular and Cellular Biology
|
October 23, 2002
Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation
Peter Akerblad, Ulrika Lind, David Liberg, et al.
Gene
|
December 3, 2002
Genomic structure of mouse SPI-C and genomic structure and expression pattern of human SPI-C
Robert Carlsson, Anna Hjalmarsson, David Liberg, et al.
Journal of Leukocyte Biology
|
July 2, 2003
RNA analysis of B cell lines arrested at defined stages of differentiation allows for an approximation of gene expression patterns during B cell development
Panagiotis Tsapogas, Thomas Breslin, Sven Bilke, et al.
Cancer Immunology, Immunotherapy : CII
|
August 29, 2022
Blockade of IL-1α and IL-1β signaling by the anti-IL1RAP antibody nadunolimab (CAN04) mediates synergistic anti-tumor efficacy with chemotherapy
Camilla Rydberg Millrud, Adnan Deronic, Caitríona Grönberg, et al.
Page
of 3